Serrano-Rios, M <br/><br/>
Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  Feb 2002 
 - 119-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0742-3071 
<br/><br/><label>Standard No.: </label>10.1046/j.1464-5491.2002.00655.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Appetite Depressants--adverse effects<br/>Body Mass Index<br/>Body Weight--drug effects<br/>Cholesterol--blood<br/>Cyclobutanes--adverse effects<br/>Diabetes Mellitus--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Male<br/>Middle Aged<br/>Obesity<br/>Placebos<br/>Sulfonylurea Compounds--adverse effects<br/>Triglycerides--blood<br/>Weight Loss--drug effects